病原微生物检验在支气管哮喘急性发作期患者临床诊治中的价值分析

The value analysis of pathogenic microbial testing in the clinical diagnosis and treatment of patients with acute attack of bronchial asthma

目的 分析支气管哮喘急性发作期患者采用病原微生物检验在临床诊治中的价值.方法 选取2022年6月-2023年6月收治的80例支气管哮喘急性发作期患者为观察对象,所有患者行病原微生物检验,收集检验结果并进行统计学比较.结果 80例患者中病原微生物检测阳性率为91.25%(73/80),阴性率为8.75%(7/80).病原菌共检测出65株,其中革兰阴性菌37株;革兰阳性菌25株;真菌3株.对比轻度、中度、重度患者的病原菌情况,重度患者卡他莫拉菌检出率低于轻度和中度患者;肺炎链球菌检出率高于轻度和中度患者,差异有统计学意义(P<0.05).临床治疗总有效率为100%.结论 病原微生物检验可以准确判断支气管哮喘急性发作期患者的病情和致病菌情况,指导临床合理用药,提高治疗效果.

Objective To analyze the value of using pathogenic microbial testing in clinical diagnosis and treatment of patients with acute exacerbation of bronchial asthma.Method 80 patients with acute exacerbation of bronchial asthma admitted from June 2022 to June 2023 were selected,and all patients underwent pathogenic microbial testing.The test results were collected and statistically compared.Result The positive rate of pathogenic microorganism detection in 80 patients was 91.25%(73/80),and the negative rate was 8.75%(7/80).A total of 65 strains of pathogenic bacteria were detected,including 37 strains of Gram negative bacteria;25 strains of Gram positive bacteria;three strains of fungi.Comparing the pathogenic bacteria situation of mild,moderate,and severe patients,the detection rate of Katamorella in severe patients is lower than that in mild and moderate patients;the detection rate of Streptococcus pneumoniae was higher than that of mild and moderate patients,and the difference was statistically significant(P<0.05).The total effective rate of clinical treatment was 100%.Conclusion Pathogenic microbial testing can accurately determine the condition and pathogenic bacteria of patients with acute exacerbation of bronchial asthma,guide clinical rational medication,and improve treatment effectiveness.